Abstract
The past 3 years have witnessed the spectacular irruption of lentiviral vectors into the limelight of the gene therapy scene. Owing to their ability to deliver transgenes in tissues that had long appeared irremediably refractory to stable genetic manipulation, lentivectors have opened fresh perspectives for the genetic treatment of a wide array of hereditary as well as acquired disorders, and a concrete proposal for their clinical use seems imminent. This article traces the path that has led to this rapid development and describes the current state of the art in the design and production of lentiviral vectors. The important question of biosafety is discussed. This system seems to have the edge over other gene delivery tools for particular targets, however, there remain several issues to be resolved before lentivectors make it to the bedside.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Roe T, Reynolds TC, Yu G, Brown PO . Integration of murine leukemia virus DNA depends on mitosis EMBO J 1993 12: 2099–2108
Lewis PF, Emerman M . Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus J Virol 1994 68: 510–516
Bukrinsky M et al. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes Proc Natl Acad Sci USA 1992 89: 6580–6584
Lewis PF, Hensel M, Emerman M . 1992. Human immunodeficiency virus infection of cell arrested in the cell cycle EMBO J 1992 11: 3053–3058
Gallay P, Stitt V, Mundy C, Oettinger M, Trono, D . Role of the karyopherin pathway in human immunodeficiency type 1 nuclear import J Virol 1996 70: 1027–1032
Bukrinsky MI et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells Nature 1993 365: 666–669
von Schwedler U, Kornbluth RS, Trono D . The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes Proc Natl Acad Sci USA 1994 91: 6992–6996
Heinzinger NK et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells Proc Natl Acad Sci USA 1994 91: 7311–7315
Gallay P, Chin D, Hope TJ, Trono D . HIV-1 infection of nondividing cells mediated through the reconition of integrase by the importin/karyopherin pathway Proc Natl Acad Sci USA 1997 94: 9825–9830
Burns JC et al. Vesicular Stomatitis Virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and non-mammalian cells Proc Natl Acad Sci USA 1993 90: 8033–8037
Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 1996 272: 263–267
Zufferey R et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat Biotechnol 1997 5: 871–875
Dull T et al. A third-generation lentivirus vector with a conditional packaging system J Virol 1998 72: 8463–8471
Miyoshi H et al. Development of a self-inactivating lentivirus vector J Virol 1998 72: 8150–8157
Zufferey R et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery J Virol 1998 72: 9873–9880
Poeschla EF, Wong-Staal F, Looney DJ . 1998. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors Nature Med 1998 4: 354–357
Olsen JC . Gene transfer vectors derived from equine infectious anemia virus Gene Therapy 1998 5: 1481–1487
White SM et al. Lentivirus vectors using human and simian immunodeficiency virus elements J Virol 1999 73: 2832–2940
Simon HM et al. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission EMBO J 1998 17: 1259–1267
Planelles V et al. Vpr-induced cell cycle arrest is conserved among primate lentiviruses J Virol 1996 70: 2516–2524
Stivahtis GL et al. Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fondamental role in primate lentivirus evolution and biology J Virol 1997 71: 4331–4338
Hart CE et al. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells Science 1989 246: 488–491
Trono D, Baltimore D . A human cell factor is essential for HIV-1 Rev action EMBO J 1990 9: 4155–4160
Blömer U et al. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector J Virol 1997 71: 6641–6649
Miyoshi H, Takahashi M, Gage FH, Verma IM . Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector Proc Natl Acad Sci USA 1997 94: 10319–10323
Takahashi M, Miyoshi H, Verme IM, Gage FH . Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer J Virol 1999 73: 7812–7816.
Han JJ et al. Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector Hum Gene Ther 1999 10: 1867–1873
Kafri T et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors Nat Genet 1997 17: 314–317
Miyoshi H et al. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors Science 1999 283: 682–686
Case SS et al. Stable transduction of quiescent CD34+ CD38- human hematopoietic cells by HIV-1-based lentiviral vectors Proc Natl Acad Sci USA 1999 96: 2988–2993
Douglas J, Kelly P, Evans JT, Garcia JV . Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors Hum Gene Ther 1999 10: 935–945
Uchida N et al. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells Proc Natl Acad Sci USA 1998 95: 11939–11944
Sutton R et al. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells J Virol 1998 72: 5781–5788
Gallichan WS et al. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis Hum Gene Ther 1998 9: 2717–2726
Poznansky M et al. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type I vector J Virol 1991 65: 532–536
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trono, D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 7, 20–23 (2000). https://doi.org/10.1038/sj.gt.3301105
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301105
Keywords
This article is cited by
-
Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)
Cellular and Molecular Life Sciences (2020)
-
Recent advances in live cell imaging of hepatoma cells
BMC Cell Biology (2014)
-
A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of Hantaan virus induced protective immunity in mice
Virology Journal (2013)
-
Optimization of Magnetic Nanoparticle-Assisted Lentiviral Gene Transfer
Pharmaceutical Research (2012)
-
Suppression of lung adenocarcinoma progression by Nkx2-1
Nature (2011)